218 related articles for article (PubMed ID: 15307132)
1. Angiopoietins in tumours: the angiogenic switch.
Tait CR; Jones PF
J Pathol; 2004 Sep; 204(1):1-10. PubMed ID: 15307132
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietins in malignancy.
Bach F; Uddin FJ; Burke D
Eur J Surg Oncol; 2007 Feb; 33(1):7-15. PubMed ID: 16962282
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietins: a link between angiogenesis and inflammation.
Fiedler U; Augustin HG
Trends Immunol; 2006 Dec; 27(12):552-8. PubMed ID: 17045842
[TBL] [Abstract][Full Text] [Related]
4. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
7. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.
Schliemann C; Bieker R; Padro T; Kessler T; Hintelmann H; Buchner T; Berdel WE; Mesters RM
Haematologica; 2006 Sep; 91(9):1203-11. PubMed ID: 16956819
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma.
Konstantinou K; Yamamoto K; Ishibashi F; Mizoguchi Y; Kurata M; Nakagawa Y; Suzuki K; Sawabe M; Ohta M; Miyakoshi S; Crawley JT; Kitagawa M
Br J Haematol; 2009 Mar; 144(5):696-704. PubMed ID: 19120365
[TBL] [Abstract][Full Text] [Related]
10. Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma.
Emoto M; Charnock-Jones DS; Licence DR; Ishiguro M; Kawai M; Yanaihara A; Saito T; Hachisuga T; Iwasaki H; Kawarabayashi T; Smith SK
Gynecol Oncol; 2004 Dec; 95(3):474-82. PubMed ID: 15581949
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin: a TIE(d) balance in tumor angiogenesis.
Shim WS; Ho IA; Wong PE
Mol Cancer Res; 2007 Jul; 5(7):655-65. PubMed ID: 17634421
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1beta.
Kalinski T; Krueger S; Sel S; Werner K; Ropke M; Roessner A
Cancer; 2006 May; 106(9):2028-38. PubMed ID: 16565972
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure.
Olsen MW; Ley CD; Junker N; Hansen AJ; Lund EL; Kristjansen PE
Neoplasia; 2006 May; 8(5):364-72. PubMed ID: 16790085
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietins in angiogenesis.
Fagiani E; Christofori G
Cancer Lett; 2013 Jan; 328(1):18-26. PubMed ID: 22922303
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer.
Lind AJ; Wikström P; Granfors T; Egevad L; Stattin P; Bergh A
Prostate; 2005 Mar; 62(4):394-9. PubMed ID: 15378518
[TBL] [Abstract][Full Text] [Related]
16. A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins.
Plank MJ; Sleeman BD; Jones PF
J Theor Biol; 2004 Aug; 229(4):435-54. PubMed ID: 15246783
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation.
Lee YL; Liu Y; Ng PY; Lee KF; Au CL; Ng EH; Ho PC; Yeung WS
Hum Reprod; 2008 Apr; 23(4):894-903. PubMed ID: 18258764
[TBL] [Abstract][Full Text] [Related]
18. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.
Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF
Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634
[TBL] [Abstract][Full Text] [Related]
19. Roles of angiopoietins in kidney development and disease.
Woolf AS; Gnudi L; Long DA
J Am Soc Nephrol; 2009 Feb; 20(2):239-44. PubMed ID: 18799719
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.
Szarvas T; Jäger T; Tötsch M; vom Dorp F; Kempkensteffen C; Kovalszky I; Romics I; Ergün S; Rübben H
Clin Cancer Res; 2008 Dec; 14(24):8253-62. PubMed ID: 19088043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
